Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia

Trial Profile

Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2014

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Torticollis
  • Focus Adverse reactions
  • Sponsors Medytox
  • Most Recent Events

    • 05 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Feb 2013 Planned End Date changed from 1 Apr 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.
    • 01 Aug 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top